IA
NAVB

IFP Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

IFP Advisors’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed -$1K – 4642
2021
Q4 		$1K Hold
50
– – ﹤0.01% 3198
2021
Q3 		$1K Hold
50
– – ﹤0.01% 3218
2021
Q2 		$0 Hold
50
– – ﹤0.01% 3350
2021
Q1 		$0 Hold
50
– – ﹤0.01% 3340
2020
Q4 		$0 Hold
50
– – ﹤0.01% 3216
2020
Q3 		$0 Hold
50
– – ﹤0.01% 3108
2020
Q2 		$0 Hold
50
– – ﹤0.01% 3080
2020
Q1 		$0 Hold
50
– – ﹤0.01% 3139
2019
Q4 		$0 Hold
50
– – ﹤0.01% 3298
2019
Q3 		$0 Buy
+50
New +$31 ﹤0.01% 3199
2019
Q1 		– Sell
-50
Closed – – 3866
2018
Q4 		$0 Hold
50
– – ﹤0.01% 4048
2018
Q3 		$0 Hold
50
– – ﹤0.01% 4140
2018
Q2 		$0 Hold
50
– – ﹤0.01% 4183
2018
Q1 		$0 Hold
50
– – ﹤0.01% 3896
2017
Q4 		$0 Sell
50
-50
-50% -$423 ﹤0.01% 4276
2017
Q3 		$1K Sell
100
-150
-60% -$1.27K ﹤0.01% 4019
2017
Q2 		$3K Hold
250
– – ﹤0.01% 3670
2017
Q1 		$3K Buy
250
+150
+150% +$1.7K ﹤0.01% 3596
2016
Q4 		$1K Hold
100
– – ﹤0.01% 3910
2016
Q3 		$2K Hold
100
– – ﹤0.01% 3658
2016
Q2 		$1K Buy
+100
New +$1.96K ﹤0.01% 3743
2016
Q1 		– Sell
-100
Closed -$3K – 3847
2015
Q4 		$3K Buy
+100
New +$3.47K ﹤0.01% 3258

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

IFP Advisors's NAVB Position: Q1 2022 in Review

IFP Advisors sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q1 2022, closing a stake of 50 shares — an estimated $1K sold.

IFP Advisors first reported a position in NAVB in Q4 2015 and held it in 22 quarters. The position peaked at $3K in Q2 2017. 25 funds tracked by Wall St. Rank hold NAVB as of Q1 2022.

  • IFP Advisors reported no remaining Navidea Biopharmaceuticals Inc. position as of Q1 2022 after selling out during the quarter.
  • IFP Advisors sold 50 Navidea Biopharmaceuticals Inc. shares in Q1 2022, an estimated $1K.
  • IFP Advisors first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2015 and held it in 22 quarters.
  • IFP Advisors's Navidea Biopharmaceuticals Inc. position peaked at $3K in Q2 2017.
  • 25 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q1 2022.

Based on IFP Advisors's 13F filing for Q1 2022, filed 8 Aug 2022.